Level Biotechnology (ROCO:3118) Dividend Payout Ratio: 0.00 (As of Dec. 2025)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Level Biotechnology Inc ROCO:3118

76 GF Score

Price NT$31.95

GF Value NT$35.57

Valuation Modestly Undervalued

2 Warning Signs

View Full Analysis

What is Level Biotechnology Dividend Payout Ratio?

Level Biotechnology ROCO:3118 +0.63% 76 Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus rates ROCO:3118 with a GF Score™ of 76/100 and a GF Value™ of NT$35.57 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 133 Biotechnology companies, Level Biotechnology ranks worse than 71.43% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Level Biotechnology's Dividend Payout Ratio for the months ended in Dec. 2025 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Level Biotechnology Inc is 0.74, which seems too high.

The historical rank and industry rank for Level Biotechnology's Dividend Payout Ratio or its related term are showing as below:

ROCO:3118' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.69 Med: 0.86 Max: 1.5
Current: 0.74

During the past 13 years, the highest Dividend Payout Ratio of Level Biotechnology was 1.50. The lowest was 0.69. And the median was 0.86.

ROCO:3118's Dividend Payout Ratio is ranked worse than
71.43% of 133 companies
in the Biotechnology industry
Industry Median: 0.44 vs ROCO:3118: 0.74

As of today (2026-07-21), the Dividend Yield % of Level Biotechnology is 6.93%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Level Biotechnology was 13.33%. The lowest was 2.64%. And the median was 5.52%.

Level Biotechnology's Dividends per Share for the months ended in Dec. 2025 was NT$0.00.

During the past 12 months, Level Biotechnology's average Dividends Per Share Growth Rate was 5.90% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -1.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 5.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -1.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Level Biotechnology was 23.90% per year. The lowest was -23.10% per year. And the median was 2.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Level Biotechnology (ROCO:3118) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Level Biotechnology Dividend Payout Ratio Related Terms

Level Biotechnology Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Level Biotechnology's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Biotechnology Dividend Payout Ratio Chart

Level Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividend Payout Ratio

Get a 7-Day Free Trial

0.76

1.06

0.88

0.86

0.74

Level Biotechnology Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Dividend Payout Ratio	Get a 7-Day Free Trial															0.00	0.00	4.01	0.00	0.00

ROCO:3118 vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Level Biotechnology's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Level Biotechnology Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Level Biotechnology's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Level Biotechnology's Dividend Payout Ratio falls into.

Save Embed

76GF Score

Level Biotechnology Inc ROCO:3118

Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Level Biotechnology Dividend Payout Ratio Calculation

Level Biotechnology's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2025 )	/	EPS without NRI (A: Dec. 2025 )
	=	1.8	/	2.439
	=	0.74

Level Biotechnology's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2025 )	/	EPS without NRI (Q: Dec. 2025 )
	=	0	/	0.56
	=	0.00

Frequently Asked Questions Learn more about Dividend Payout Ratio →

What does a Dividend Payout Ratio of 0.00 mean?

Level Biotechnology (ROCO:3118) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Level Biotechnology and its competitors. Over the past decade, Level Biotechnology's Dividend Payout Ratio has ranged from 0.69 to 1.50. According to the industry distribution chart, Level Biotechnology ranks #95 out of 133 companies in the Biotechnology industry, placing it in the top 71.4%.

Is Level Biotechnology's Dividend Payout Ratio too high?

Level Biotechnology's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 1.50. Based on the distribution chart, Level Biotechnology ranks #95 out of 133 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Level Biotechnology has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Level Biotechnology's Dividend Payout Ratio compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Level Biotechnology ranks #95 out of 133 companies for Dividend Payout Ratio. This places Level Biotechnology in the lower half of its industry. The industry median Dividend Payout Ratio is 0.44. Historically, Level Biotechnology's own Dividend Payout Ratio has ranged from 0.69 to 1.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividend Payout Ratio for a Biotechnology company?

The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 133 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividend Payout Ratio mean?

A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Level Biotechnology and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Level Biotechnology's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Level Biotechnology stock overvalued right now?

Based on GuruFocus' analysis, Level Biotechnology (ROCO:3118) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$35.57, compared to a current price of NT$31.95 — trading 10.2% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Level Biotechnology's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividend Payout Ratio calculated?

Dividend Payout Ratio is calculated from a company's financial statements. For Level Biotechnology (ROCO:3118), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Level Biotechnology (ROCO:3118) Overvalued in 2026?

Based on GuruFocus' analysis, Level Biotechnology stock appears to be undervalued. The current stock price of NT$31.95 is trading 10.2% below its estimated GF Value™ of NT$35.57. GuruFocus considers Level Biotechnology to be Modestly Undervalued.

Key valuation signals for ROCO:3118:

Dividend Payout Ratio: 0.00
GF Value™: NT$35.57 vs. price of NT$31.95 (10.2% below fair value)
GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the ROCO:3118 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Level Biotechnology Business Description

Industry Healthcare Biotechnology

Comparable Companies ROCO:6814 ROCO:4194 ROCO:4724 ROCO:6879 ROCO:6827 ROCO:4171 ROCO:6876 ROCO:6564 ROCO:6850 ROCO:7725 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address No. 80, Lane 169, Kangning Street, Xizhi District, New Taipei City, TWN, 221

Website https://www.level.com.tw

Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services. The company has three reportable segments: Department A and B, Department C, and Department D. Department A and Department B sell the cell culture consumables and the antibody reagents, Department C sells the instruments and equipment, and Department D provides CRO services. The majority of revenue is derived from the Department A and B.

76GF Score

Get the complete analysis for ROCO:3118

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.95

Price

NT$35.57

GF Value

View ROCO:3118 Analysis

See Dividend Payout Ratio data for all stocks →